Fischbach M, Edefonti A, Schröder C, Watson A
Nephrology Dialysis Transplantation Children's Unit, University Hospital, Strasbourg, France.
Pediatr Nephrol. 2005 Aug;20(8):1054-66. doi: 10.1007/s00467-005-1876-y. Epub 2005 Jun 10.
Over the past 20 years children have benefited from major improvements in both technology and clinical management of dialysis. Morbidity during dialysis sessions has decreased with seizures being exceptional and hypotensive episodes rare. Pain and discomfort have been reduced with the use of chronic internal jugular venous catheters and anesthetic creams for fistula puncture. Non-invasive technologies to assess patient target dry weight and access flow can significantly reduce patient morbidity and health care costs. The development of urea kinetic modeling enables calculation of the dialysis dose delivery, Kt/V, and an indirect assessment of the intake. Nutritional assessment and support are of major importance for the growing child. Even if the validity of these "urea only" data is questioned, their analysis provides information useful for follow-up. Newer machines provide more precise control of ultrafiltration by volumetric assessment and continuous blood volume monitoring during dialysis sessions. Buffered bicarbonate solutions are now standard and more biocompatible synthetic membranes and specific small size material dialyzers and tubing have been developed for young infants. More recently, the concept of "ultrapure" dialysate, i.e. free from microbiological contamination and endotoxins, has developed. This will enable the use of hemodiafiltration, especially with the on-line option, which has many theoretical advantages and should be considered in the case of maximum/optimum dialysis need. Although the optimum dialysis dose requirement for children remains uncertain, reports of longer duration and/or daily dialysis show they are more effective for phosphate control than conventional hemodialysis and should be considered at least for some high-risk patients with cardiovascular impairment. In children hemodialysis has to be individualized and viewed as an "integrated therapy" considering their long-term exposure to chronic renal failure treatment. Dialysis is seen only as a temporary measure for children compared with renal transplantation because this enables the best chance of rehabilitation in terms of educational and psychosocial functioning. In long term chronic dialysis, however, the highest standards should be applied to these children to preserve their future "cardiovascular life" which might include more dialysis time and on-line hemodiafiltration with synthetic high flux membranes if we are able to improve on the rather restricted concept of small-solute urea dialysis clearance.
在过去20年里,儿童在透析技术和临床管理方面都取得了重大进步。透析过程中的发病率有所下降,癫痫发作极为罕见,低血压发作也很少见。使用慢性颈内静脉导管和用于瘘管穿刺的麻醉膏减少了疼痛和不适。评估患者目标干体重和通路血流量的非侵入性技术可显著降低患者发病率和医疗成本。尿素动力学模型的发展使得能够计算透析剂量输送(Kt/V)并间接评估摄入量。营养评估和支持对成长中的儿童至关重要。即使这些“仅尿素”数据的有效性受到质疑,其分析也能提供对随访有用的信息。新型机器通过体积评估和透析过程中的连续血容量监测,能更精确地控制超滤。缓冲碳酸氢盐溶液现已成为标准配置,并且已经为幼儿开发出了生物相容性更好的合成膜以及特定尺寸较小的材料制成的透析器和管路。最近,“超纯”透析液的概念已经形成,即不含微生物污染和内毒素。这将使得血液透析滤过能够得以应用,特别是在线模式,其具有许多理论优势,在需要最大程度/最佳透析时应予以考虑。尽管儿童最佳透析剂量需求仍不确定,但关于更长透析时间和/或每日透析的报告表明,它们在控制磷方面比传统血液透析更有效,至少对于一些有心血管损害的高危患者应予以考虑。在儿童中,血液透析必须个体化,并应被视为一种“综合治疗”,因为要考虑到他们长期接受慢性肾衰竭治疗的情况。与肾移植相比,透析对儿童来说只是一种临时措施,因为肾移植在教育和心理社会功能方面能提供最佳的康复机会。然而,在长期慢性透析中,应该为这些儿童采用最高标准,以保护他们未来的“心血管健康”,如果我们能够改进目前关于小分子溶质尿素透析清除率的相当有限的概念,这可能包括更多的透析时间以及使用合成高通量膜进行在线血液透析滤过。